Reid Merryman, MD, on Potential Clinical Designs with MRD-Guidance for Patients with DLBCL
Expert details the potential for a clinical trial using minimal residual disease to guide therapy for patients with DLBCL.
Reid Merryman, MD, on Pre- and Post-Transplant Data for Patients with DLBCL
Merryman explains the value of evaluating separate transplant-related questions for patients with relapsed or refractory diffuse large B-cell lymphoma.
Reid Merryman, MD, on Study Findings Investigating Prognostic Value of ctDNA for Patients with DLBCL
Thought leader detailed the findings from an oral presentation investigating patients with relapsed or refractory diffuse large B-cell lymphoma.
Reid Merryman, MD, Discusses Autologous Stem Cell Transplantation for Patients with DLBCL
Merryman provided background for the study design investigating patients with relapsed or refractory diffuse large B-cell lymphoma.